New Search

Your search found 18 records, sorted by year and then date of acquisition.

1. Opioid Addicted Buprenorphine Injectors: Drug Use During and After 12-Weeks of Buprenorphine-Naloxone or Methadone in the Republic of Georgia. doc type
  Piralishvili, Gvantsa ; Otiashvili, David ; Sikharulidze, Zura ; Kamkamidze, George ; Poole, Sabrina A. ; Woody, George E.
 Journal of Substance Abuse Treatment 2015;50:32-37. [doi: 10.1016/j.jsat.2014.10.003].
 
2. Buprenorphine Suite of Blending Products (Blending Team Product). doc type doc type
  Blending Team Members
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2005-2012.
 
3. Gender and Racial/Ethnic Differences in Addiction Severity, HIV Risk, and Quality of Life among Adults in Opioid Detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network. doc type
  Wu, Li-Tzy ; Ling, Walter ; Burchett, Bruce ; Blazer, Dan G. ; Shostak, Jack ; Woody, George E.
 Substance Abuse and Rehabilitation 2010;1:13-22. [doi: 10.2147/SAR.S15151].
 
4. Opioid Treatment Programs in the Clinical Trials Network: Representativeness and Buprenorphine Adoption. doc type
  Ducharme, Lori J. ; Roman, Paul M.
 Journal of Substance Abuse Treatment 2009;37(1):90-94. [doi: 10.1016/j.jsat.2008.09.003].
 
5. Addiction Treatments of the Future: The Role of Genetics. doc type
  Kreek, Mary Jeanne ; Haynes, Louise F. ; Cohen, Allan J.
 Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.
 
6. Statistical Methodology for a SMART Design in the Development of Adaptive Treatment Strategies. doc type
  Scott, Alena I. ; Levy, Janet A. ; Murphy, Susan A.
 State College, PA : The Methodology Center, Pennsylvania State University, Technical Report #07-82, 2007, 30p..
 
7. Integrating Services Research into CTN Clinical Trials: The Synergy is in the Details. doc type
  Perl, Harold I.
 Presented at the Addiction Health Services Research Conference, October 15-17, 2007, Athens, GA.
 
8. A Federal Effort to Bridge the Gap: NIDA's Blending Initiative Places Community Providers at the Leading Edge of New Treatment Knowledge. doc type
  Condon, Timothy P.
 Addiction Professional 2007;5(5):26-31.
 
9. The Science of Treatment: Dissemination of Research-Based Drug Addiction Treatment Findings (Blending Team Product). doc type
  National Institute on Drug Abuse (NIDA) ; Substance Abuse and Mental Health Services Administration (SAMHSA) ; Addiction Technology Transfer Center (ATTC) National Office
 Produced by the NIDA/SAMHSA-ATTC Blending Initiative, 2007.
 
10. Research Network Involvement and Addiction Treatment Center Staff: Counselor Attitudes toward Buprenorphine. doc type
  Knudsen, Hannah K. ; Ducharme, Lori J. ; Roman, Paul M.
 American Journal on Addictions 2007;16(5):365-371 [doi: 10.1080/10550490701525418].
 
11. Innovation Adoption in Substance Abuse Treatment: Exposure, Trialability, and the Clinical Trials Network. doc type
  Ducharme, Lori J. ; Knudsen, Hannah K. ; Roman, Paul M. ; Johnson, J. Aaron
 Journal of Substance Abuse Treatment 2007;32:321-329. [doi: 10.1016/j.jsat.2006.05.021].
 
12. Using Buprenorphine in Opioid Treatment Programs. doc type
  Cohen, Allan J.
 Presented at the American Association for the Treatment of Opioid Dependence (AATOD) annual meeting, Atlanta, GA, April 2006.
 
13. Short Term Opioid Withdrawal Using Buprenorphine (Blending Team Product). doc type
  Freese, Thomas E. ; Brigham, Gregory S. ; Finnerty, Beth ; Gresham-Morrison, Kay ; Harrer, Judith M. ; McCarty, Dennis ; Storti, Susan A.
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2006.
 
14. Challenges in the Adoption of New Pharmacotherapeutics for Addiction to Alcohol and Other Drugs. doc type
  Saxon, Andrew J. ; McCarty, Dennis
 Pharmacology & Therapeutics 2005;108:119-128. [doi: 10.1016/j.pharmthera.2005.06.014].
 
15. Buprenorphine Treatment: A Training for Multidisciplinary Addiction Professionals (Blending Team Product) doc type doc type
  Amass, Leslie ; Brigham, Gregory S. ; Clare, Glenda ; Dixon, Gail ; Finnerty, Beth ; Freese, Thomas E. ; Strain, Eric ; Martin, Judith ; McCann, Michael J. ; Obert, Jeanne L. ; Wesson, Donald ; Addiction Technology Transfer Center (ATTC) National Office ; OASIS Clinic
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2005.
 
16. Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience. doc type
  Amass, Leslie ; Ling, Walter ; Freese, Thomas E. ; Reiber, Chris ; Annon, Jeffrey J. ; Cohen, Allan J. ; McCarty, Dennis ; Reid, Malcolm S. ; Brown, Lawrence S. Jr. ; Clark, Cynthia ; Ziedonis, Douglas M. ; Krejci, Jonathan ; Stine, Susan M. ; Winhusen, Theresa M. ; Brigham, Gregory S. ; Babcock, Dean ; Muir, Joan A. ; Buchan, Betty J. ; Horton, Terry
 American Journal on Addictions 2004; 13 (Suppl 1): S42-S66. [doi: 10.1080/10550490490440807].
 
17. Buprenorphine/Naloxone versus Clonidine for Opiate Detoxification : A Medication Comparison Study. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
18. Buprenorphine/Naloxone versus Clonidine for Opiate Detoxification : A Medication Comparison Study. Now That I've Joined. . . doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 

New Search